Gamma Knife Market Share to Witness Steady Rise in the Coming Decade

The global gamma knife market secured US$ 172 Mn in 2015, and is expected to grow at more than 9% CAGR through 2025, accounting for over US$ 400 Mn in terms of revenues. Strong growth is expected in regions such as India, South Korea, the U.S., Japan, EU5 and China. Varian and Elekta medical systems are likely to retain their dominance in developed economies, whereas Huiheng Medical, Inc. based at China will consolidate its position in Asia Pacific. Currently, North America, the biggest market for the gamma knife is likely to demote to second position due to robust acceptance of the gamma knife equipment in Asia Pacific.

Drivers and Trends of Market

Inclination towards non-invasive treatments have positively impacted adoption of radiation therapy, with Gamma Knife, LINAC and Cyber Knife gaining traction in healthcare sector. Positive perception toward gamma knife, rising preference for minimally-invasive surgeries and huge success rate are among the key factors anticipated to propel adoption of gamma knife treatment over the forecast period. Medical tourism, emphasis on R&D and increasing expenditure per capita on healthcare are some other factors anticipated to support growth of the market in long run. Improvements in technology that makes gamma knife more effective and safer are also expected to expand its adoption among end-users throughout the forecast period. Yet, high cost continues to be main challenge for widespread adoption and is likely to limit its adoption in developing economies.
Request For Report Sample with Table of Contents@https://www.researchsolutioninsights.com/report/sample/230118-Gamma-Knife-Market
Brain Metastasis to Remain Largest Disease Indication Segment

Gamma knife treatment is applicable to treat various disease indications, including trigeminal neuralgia, cancer, brain metastasis, and AVM. Among these, application of gamma knife for remedying brain metastasis is likely to account for significant percentage of total market revenues, trailed by cancer and trigeminal neuralgia. Brain metastasis is likely to remain largest disease indication segment for gamma knife market over the forecast period.

Asia Pacific Gamma Knife Market to Expand at Significant CAGR

Asia Pacific is likely to pip both Europe and North America to emerge as the largest market for gamma knife by 2025-end. Increasing adoption of gamma knife equipment in India, South Korea, Japan, and China will support expansion of the gamma knife market in Asia Pacific. The gamma knife market in Asia Pacific is estimated to expand at CAGR of more than 10% throughout the forecast period. APEJ will emerge as more lucrative region than Europe and North America however, collectively secure nearly two-fourth revenue share of the global gamma knife market by the end of 2025.
Request For Report Discount@https://www.researchsolutioninsights.com/report/discount/230118-Gamma-Knife-Market
Prominent Market Player’s Strategies to Maintain Market Position

Huiheng Medical, Inc., Elekta, and Varian Medical Systems are prominent gamma knife equipment manufacturers. These players are likely to maintain their position in the market through continuous innovative product development and stepping in into new markets

Research Solution Insights is a U.S. based market research and consulting company.
We are the best destination for your research and analytical solutions;
simply because our primary and secondary sources of information are adroit to give one stop solutions.
Company provides syndicated research reports,customized research reports, and consulting services.

We offer the comprehensive market research solutionfor all the industries by performing the in-depth study of industry trends,
verticals globally.We believe in building an eternal bond with our customers through providing
them inclusive research study both customized and syndicated based on their specific requirements.

10 rue Pierre Grange,
Zone industrielle de la pointe,
94120 Fontenay sous Bois

This release was published on openPR.